The Cancer Patent Cliff: Why Watchful Waiting May Be The Best Rx For High Drug Costs
Executive Summary
As efforts are made to try new reimbursement and pricing models to address concerns about the price of cancer drugs, one option is to wait and see if generics and biosimilars solve the problem.